...
机译:必不可少的手术病理学家在乳腺癌治疗计划中的作用
David G. Hicks, MD, Swati Kulkarni, MD, M. Elizabeth H. Hammond, MDAccepted for publication April 2, 2008.From the Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY (Dr Hicks), the Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY (Dr Kulkarni), and the Department of Pathology and Laboratory Medicine, LDS Hospital, Salt Lake City, Utah (Dr Hammond).The authors have no relevant financial interest in the products or companies described in this article.Reprints: David G. Hicks, MD, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Box 626, Rochester, NY 14642 (e-mail: David_Hicks@urmc.rochester.edu).,;
机译:必不可少的手术病理学家在乳腺癌治疗计划中的作用
机译:外科肿瘤学会-美国放射肿瘤学会关于一期和二期全乳照射保乳手术利润率的共识指南,病理学家的观点
机译:病理学家在Neoadjuvant治疗乳腺癌管理中的不断发展的作用:基于西班牙临床经验的建议
机译:CO2激光刀在乳腺癌手术中的应用
机译:种族差异在乳腺癌的外科治疗和放射治疗中的使用。
机译:乳腺癌乳腺癌外科治疗乳腺癌治疗分析的有用性 - 初级可操作乳腺癌患者分析
机译:乳房病理学家是否存在乳房病态的诊断挑战,Pr和Her2在原发性乳腺癌和脑转移之间?